GGrantIndex
Sort

130,381 grants matching hiv

MUCOSAL IMMUNITY IN THE HUMAN FEMALE REPRODUCTIVE TRACT

$785,792
Dartmouth College · P01 · FY2000 · AI

Investigating and identifying the heterogeneity in COVID-19 misinformation exposure on social media among Black and Rural communities to inform precision public health messaging

$785,747
Sharath Chandra Guntuku · University Of Pennsylvania · R01 · FY2023 · MD

Evaluating the effectiveness of a mobile HIV prevention app to increase HIV and STI testing and PrEP initiation among rural men who have sex with men

$785,728
Jeb Jones · Emory University · R01 · FY2023 · MH

Evaluating a Youth focused economic empowerment approach to HIV Treatment

$785,715
Fred M Ssewamala · Columbia Univ New York Morningside · R01 · FY2012 · HD

Functions of KSHV microRNAs

$785,709
Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound

$785,703
Mirko Paiardini · Emory University · R01 · FY2021 · MH

Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse

$785,684
Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2022 · DA

Formulation Development and Clinical Manufacturing: Manufacture of TLC-ART101 Bulk Product for Clinical Trials

$785,631
Jon Mirsalis · Sri International · N01 · FY2020 · AI

Pediatric AIDS Clinical Trials Group

$785,626
Stephen A Spector · University Of California, San Diego · U01 · FY2006 · AI

Stellenbosch University Clinical Trial Unit, Cape Town, South Africa

$785,614
Mark Fredric Cotton · Stellenbosch University · UM1 · FY2013 · AI

Long-Acting Prevention Implantable System (LAPIS) for HIV Pre-Exposure Prophylaxis (PrEP)

$785,575
Leah Johnson · Research Triangle Institute · R01 · FY2020 · AI

Enhanced problem-solving therapy and HIV engagement support to improve perinatal mental health and HIV outcomes in Malawi: A randomized controlled trial

$785,514
Brian W Pence · Univ Of North Carolina Chapel Hill · R01 · FY2024 · MH

Disease Status Drug Metabolism

$785,510
Irving William Wainer · National Institute On Aging · Z01 · FY2008 · AG

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$785,421
Loretta Emily Haddy · West Virginia State Dept Hlth/Human Rscs · U62 · FY2015 · PS

Combinatorial and computational design of bnAb mRNA vaccines for HIV

$785,418
Daniel G Anderson · Massachusetts Institute Of Technology · R61 · FY2023 · AI

The role of PrEP in Getting to Zero

$785,414
Daniel Escudero · Vanderbilt University Medical Center · R01 · FY2024 · AI

Computational design and development of small protein inhibitors

$785,407
Eva-Maria Strauch · Washington University · R01 · FY2024 · AI

MVA Prime/Novel Trimeric Cyclically Permuted Envelope Protein Boost Vaccines for HIV

$785,398
Rama Rao Amara · Emory University · R01 · FY2022 · AI

Protective Human Monoclonal Antibodies to HIV-1

$785,373
Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2009 · HL

STRENGTHENING THE INDONESIAN MILITARY RESPONSE TO HIV

$785,368
Family Health International · · FY2012 · Department of Defense

Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load

$785,363
Chinazo Cunningham · Albert Einstein College Of Medicine · R01 · FY2011 · DA

Identification of SIV replication and reservoirs in the CNS

$785,354
Francois J Villinger · University Of Louisiana At Lafayette · R01 · FY2023 · MH

Retrovirus Biology

$785,353
Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection

$785,351
Megan A O'Connor · University Of Washington · R01 · FY2024 · HL

INTERVENTION TO REDUCE INJECTION DRUG USE

$785,308
University Of Colorado Denver · R01 · FY2003 · DA